Vecuronium and d‐Tubocurarine Combination: Potentiation of Effect

To evaluate possible potentiation of neuromuscular blocking effect of a combination of vecuronium and d-tubocurarine, cumulative dose-response curves were constructed to compare the potency of this combination with vecuronium arid d-tubocurarine given alone. Teri patients each were given incremental injections of 80 μg/kg d-tubocurarine or 5 μg/kg vecuronium plus 40 μg/kg d-tubocurarine, the data for incremental administration of 10 μg/kg vecuronium being used from our previously published study (7). The results showed the combination of vecuronium plus d-tubocurarine to be significantly more potent (P < 0.05) than would be expected from a simple additive effect of the individual drugs given alone. The ED95 doses of d-tubocurarine and vecuronium were 530 μg/kg and 57 μg/kg, respectively, when administered alone, but when administered together, the ED95 doses were 160 and 20 μg/kg, respectively.

[1]  R. Mirakhur,et al.  Dose-response studies with pancuronium, vecuronium and their combination. , 1984, British journal of clinical pharmacology.

[2]  F. Donati,et al.  Differential effects of myoneural blocking drugs on neuromuscular transmission in infants. , 1984, British journal of anaesthesia.

[3]  R. Mirakhur,et al.  Time Course of Muscle Relaxation with a Combination of Pancuronium and Tubocurarine , 1984, Anesthesia and analgesia.

[4]  J. Dundee,et al.  Clinical evaluation of Org NC 45. , 1983, British journal of anaesthesia.

[5]  R. M. Jones,et al.  Interactions between tubocurarine, pancuronium and alcuronium demonstrated in the rat phrenic nerve-hemidiaphragm preparation. , 1983, British journal of anaesthesia.

[6]  M. Cahalan,et al.  The Cardiovascular Effects of Vecuronium (ORG NC45) and Pancuronium in Patients Undergoing Coronary Artery Bypass Grafting , 1983, Anesthesiology.

[7]  R. Matteo,et al.  Competitive Nonspecific Binding Does Not Explain the Potentiating Effects of Muscle Relaxant Combinations , 1983, Anesthesia and analgesia.

[8]  C. Shanks Dose-Response Curves for Alcuronium and Pancuronium Alone and in Combination , 1982, Anaesthesia and intensive care.

[9]  J. Viby-Mogensen,et al.  Clinical assessment of neuromuscular transmission. , 1982, British journal of anaesthesia.

[10]  R. Miller,et al.  Clinical Pharmacology of ORG NC45 (NorcuronTM): A New Nondepolarizing Muscle Relaxant , 1981, Anesthesiology.

[11]  H. H. Ali,et al.  Combination of Pancuronium and Metocurine: Neuromuscular and Hemodynamic Advantages over Pancuronium Alone , 1981, Anesthesia and analgesia.

[12]  W. Bowman Prejunctional and Postjunctional Cholinoceptors at the Neuromusclar Junction , 1980, Anesthesia and analgesia.

[13]  T. N. Calvey,et al.  Differential effects of myoneural blocking drugs on neuromuscular transmission. , 1980, British journal of anaesthesia.

[14]  H. H. Ali,et al.  Potentiation of Neuromuscular Blockade in Man Produced by Combinations of Pancuronium and Metocurine or Pancuronium and d‐Tubocurarine , 1980, Anesthesia and analgesia.

[15]  A. Galindo Curare and pancuronium compared: effects on previously undepressed mammalian myoneural junctions. , 1973, Science.

[16]  J. P. Long,et al.  The interaction between d-tubocurarine and gallamine during halothane anaesthesia , 1972, Canadian Anaesthetists' Society journal.

[17]  K. C. Wong,et al.  Some Synergistic Effects of d‐Tubocurarine and Gallamine , 1971, Anesthesia and analgesia.